iBio Inc Sustainability Reports
iBio, Inc. is a biotechnology company that leverages artificial intelligence and advanced computational biology to design and develop next-generation antibody therapeutics. The company's pipeline primarily targets obesity, cardiometabolic diseases, and cancer.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900EW4RXUITGKUT34
FIGI: BBG001T0R8W3
12 reports from 2008 to 2026
